Table 2 Patient and primary tumor characteristics
From: Radiosurgery and fractionated stereotactic body radiotherapy for patients with lung oligometastases
Characteristics | No. (%) |
|---|---|
Age, years | |
Median | 66 |
Range | 26 - 84 |
Gender | |
Female | 20 (38.5) |
Male | 32 (61.5) |
KPS (%) | |
Median | 80 |
Range | 60 - 100 |
Primary tumor type | |
CRC | 17 (32.7) |
Sarcoma | 8 (15.4) |
Melanoma | 7 (13.5) |
HNC | 6 (11.5) |
RCC | 5 (9.6) |
NSCLC | 3 (5.8) |
Others | 6 (11.5) |
T-classification at initial diagnosis | |
T≤2 | 17 (32.7) |
T>2 | 30 (57.7) |
Unknown | 5 (9.6) |
N-classification at initial diagnosis | |
N0 | 18 (34.6) |
N+ | 26 (50.0) |
Unknown | 8 (15.4) |
M-classification at initial diagnosis | |
M0 | 36 (69.2) |
M1 | 12 (23.1) |
Unknown | 4 (7.7) |
Pre-SFRS/fSBRT systemic therapy | |
Yes | 46 (88.5) |
No | 6 (11.5) |
No. of LM treated with SFRS/fSBRT per patient | |
Median | 2 |
Range | 1 - 5 |
No. of affected organs per patient | |
Median | 1 |
Range | 1 - 4 |